Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Marker Assessment in Multiple Myeloma with Zoledronic Acid
NCT00577642Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2007
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in multiple myeloma (MM), sponsored by Massachusetts General Hospital. Started Oct 2007; status: completed.
02
Drugs
zoledronic acid
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00577642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577642.